Jump to content

Talk:Modafinil

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia


Borderline sources

[edit]

I've noticed that the script User:Headbomb/unreliable.js marks a few sources in the Modafinil article as borderline, such as doi:10.3389/fnins.2021.656475. User:JoelleJay can you please help us sorting out these yellow sources in Modafinil, such as (a) replacing them with better sources, (b) adding a comment that a source is appropriate in this particular case via, for example, <!-- --> or some other way, or (c) removing a statement when there are no good sources left. I am not very good in distinguishing really bad sources that should be removed from marginally bad that can be kept. Can you please help in that and/or guide me what should I do on each of those sources, or maybe there are other options to address yellow sources? Maxim Masiutin (talk) 15:52, 22 April 2024 (UTC)[reply]

Sure, I can look into replacement sources. JoelleJay (talk) 17:03, 22 April 2024 (UTC)[reply]
Thank you very much, will be looking for your feedback. Maxim Masiutin (talk) 19:12, 22 April 2024 (UTC)[reply]
I'll try to get to it this week, unless there is a time constraint here? JoelleJay (talk) 02:54, 24 April 2024 (UTC)[reply]
There is no time constraint, please do that when you have time if at all. Thank you! Maxim Masiutin (talk) 15:41, 24 April 2024 (UTC)[reply]

Drug Tolerance

[edit]

The section on drug tolerance contradicts itself. The first para states that "Extensive clinical research has not demonstrated drug tolerance...."; the next four paras describe development of tolerance! The first para references different cites from the remainder of the section. One would need to check these references rather carefully to see what confidence can be placed in this opening statement, and whether it needs to be qualified. I believe modafinil has a much lower risk of developing tolerance in short-term or occasional use than the amphetamines, but I would be very surprised if it were shown to have no tolerance after 40 weeks of regular use.

The rest of the section is a bit verbose and could be redacted.

I don't have time in the next couple of days to do the edit justice, but I'll keep this on my to do list. As usual, feel free to preempt me ;-) D Anthony Patriarche (talk) 17:09, 10 July 2024 (UTC)[reply]

State of this article

[edit]

I don't know about reference bureaucracy in English Wikipedia, but this article now feels like heavy based on critique and make modafinil to sound like as "inferior amphetamine". I would like to remind that is very mild drug in it's psychoactivity, more comparable to caffeine, regardless of drug laws.

Adverse effects like severe allergic reactions is very rare and should be stated as such in introduction. The most common one is headache. While this is abused a lot, there are contradictory research about addiction potential and tolerance to this drug. Even if there is, it's definitely not similar to classic dopamine drugs. Euphoria is more like a rare adverse effect. Probably more people will perceive it as dysphoric from increased anxiety. Also, trying to state stimulant doesn't increase cognitive functioning, is like saying that water isn't wet.

I won't change anything here, just my impression about where this is heading to recent months. --GreenZeb (talk) 07:01, 4 August 2024 (UTC)[reply]